Transparency demands could threaten early trial investment
PharmaTimes
All the same, Bates commented, there was “nervousness” among BIA members about the amendments on data transparency tabled in her rapporteur's report by Labour MEP Glenis Willmott, who addressed last week's meeting organised by the European